Latest news about Evinex
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
There is no available information on "Evinex" from the provided sources, as they all pertain to "Evaxion Biotech." Here is a summary for Evaxion instead: Evaxion regained Nasdaq compliance by restoring equity above the minimum requirement through capital raises and will remain listed. The company's cash runway extends to mid-2026, and it is on track with its 2025 milestones, including the EVX-01 phase 2 trial and advancing its AI-Immunology™ platform[2][4][5].
There is no recent significant news available for "Evinex" from the provided sources, as they do not mention any recent developments or news related to Evinex.
There is no recent significant news available for "Evinex" from the provided sources, as they do not mention any recent developments or news related to Evinex.
Open job positions at Evinex
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

